UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $165

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $158 to $165.

Benzinga · 11/06/2019 12:41

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $158 to $165.